Andrew Wiseman Ph.D.
Senior Consultant
Andrew Wiseman brings more than 25 years of experience in the biotechnology industry, primarily in investor relations and medical communications. He has 15 years of experience managing the investor relations program inside a public company, and played an important role in bringing the company from a start up, through the IPO process, into the public company arena. He has a reputation on Wall Street of being one of the strongest scientific investor relations professionals in the biotech community.
Dr. Wiseman has a particular strength in building, managing and implementing highly effective investor relations, business development and medical marketing programs. He has a proven ability to rapidly assimilate and integrate new and diverse highly technical and business information – resulting in the successful management of different areas of a dynamically changing small company. He has a broad knowledge of pharmaceutical product development, biomedical and pharmaceutical sciences and extensive knowledge, experience, and contacts with other pharmaceutical and biotechnology companies. Dr. Wiseman has a demonstrated ability to communicate complex science and business to both highly technical and non-technical audiences.
Dr. Wiseman was a founder and Head of Investor Relations at La Jolla Pharmaceutical Company where he also was responsible for key opinion leader and patient advocacy development in support of the Company’s efforts to bring the first drug to patients with systemic lupus erythematosus. He also led the Company’s business development team for 10 years. He was a key player in the Company’s successful fundraising of approximately $350 million from both private and public investors in support of its product development activities. Prior to founding La Jolla Pharmaceutical, he worked in business development and product development at Quidel, an immunodiagnostics company.
Before joining the biotechnology industry, Dr. Wiseman was an Assistant Professor in the Department of Cell Biology at the Research Institute of Scripps Clinic in La Jolla